Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study

References

• KleinRLeeKEGangnonREKleinBEThe 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathyOphthalmology20101171637019880184
   PubMed Web of Science ®Google Scholar
• MossSEKleinRKleinBEThe 14-year incidence of visual loss in a diabetic populationOphthalmology1998105699810039627648
   PubMed Web of Science ®Google Scholar
• YauJWRogersSLKawasakiRGlobal prevalence and major risk factors of diabetic retinopathyDiabetes Care201235355656422301125
   PubMed Web of Science ®Google Scholar
• MinassianDCOwensDRReidyAPrevalence of diabetic macular oedema and related health and social care resource use in EnglandBr J Ophthalmol201296334534921602478
   PubMed Web of Science ®Google Scholar
• KleinRKleinBEMossSECruickshanksKJThe Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edemaOphthalmology199510217167831044
   PubMed Web of Science ®Google Scholar
• BhagatNGrigorianRATutelaAZarbinMADiabetic macular edema: pathogenesis and treatmentSurv Ophthalmol200954113219171208
   PubMed Web of Science ®Google Scholar
• AntonettiDALiethEBarberAJGardnerTWMolecular mechanisms of vascular permeability in diabetic retinopathySemin Ophthalmol199914424024810758225
   PubMedGoogle Scholar
• EhrlichRHarrisACiullaTAKheradiyaNWinstonDMWirostkoBDiabetic macular oedema: physical, physiological and molecular factors contribute to this pathological processActa Ophthalmol201088327929120222885
   PubMed Web of Science ®Google Scholar
• FunatsuHNomaHMimuraTEguchiSHoriSAssociation of vitreous inflammatory factors with diabetic macular edemaOphthalmology20091161737919118698
   PubMed Web of Science ®Google Scholar
• JoussenAMPoulakiVLeMLA central role for inflammation in the pathogenesis of diabetic retinopathyFASEB J200418121450145215231732
   PubMed Web of Science ®Google Scholar
• KlaassenIVan NoordenCJSchlingemannROMolecular basis of the inner blood–retinal barrier and its breakdown in diabetic macular edema and other pathological conditionsProg Retin Eye Res201334194823416119
   PubMed Web of Science ®Google Scholar
• TangJKernTSInflammation in diabetic retinopathyProg Retin Eye Res201130534335821635964
   PubMed Web of Science ®Google Scholar
• FunatsuHYamashitaHNomaHAqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patientsGraefes Arch Clin Exp Ophthalmol200524313815258777
   PubMed Web of Science ®Google Scholar
• DongNXuBWangBChuLStudy of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathyMol Vis2013191734174623922491
   PubMed Web of Science ®Google Scholar
• DasAMcGuirePGRangasamySDiabetic macular edema: pathophysiology and novel therapeutic targetsOphthalmology201512271375139425935789
   PubMed Web of Science ®Google Scholar
• WellsJAGlassmanARAyalaARDiabetic Retinopathy Clinical Research NetworkAflibercept, bevacizumab, or ranibizumab for diabetic macular edemaN Engl J Med2015372131193120325692915
   PubMed Web of Science ®Google Scholar
• AveryRLGordonGMSystemic safety of prolonged monthly anti-vascular endothelial growth factor therapy for diabetic macular edema: a systematic review and meta-analysisJAMA Ophthalmology20152129
   Web of Science ®Google Scholar
• CallananDGGuptaSBoyerDSOzurdex PLACID Study GroupDexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edemaOphthalmology201312091843185123706947
   PubMed Web of Science ®Google Scholar
• KaneFEBurdanJCutinoAGreenKEIluvien: a new sustained delivery technology for posterior eye diseaseExpert Opin Drug Deliv2008591039104618754752
   PubMed Web of Science ®Google Scholar
• CampochiaroPANguyenQDHafizGFAMOUS Study GroupAqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implantsOphthalmology2013120358358723218184
   PubMed Web of Science ®Google Scholar
• CampochiaroPABrownDMPearsonAFAME Study GroupSustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edemaOphthalmology2012119102125213222727177
   PubMed Web of Science ®Google Scholar
• CampochiaroPABrownDMPearsonAFAME Study GroupLong-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edemaOphthalmology2011118462663521459216
   PubMed Web of Science ®Google Scholar
• ILUVIEN®Summary of Product Characteristics Available from: https://www.medicines.org.uk/emc/medicine/27636Accessed May 30, 2016
   Google Scholar
• BresslerSBQinHBeckRWDiabetic Retinopathy Clinical Research NetworkFactors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumabArch Ophthalmol201213091153116122965591
   PubMedGoogle Scholar
• BrowningDJGlassmanARAielloLPDiabetic Retinopathy Clinical Research NetworkRelationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edemaOphthalmology2007114352553617123615
   PubMed Web of Science ®Google Scholar
• AlasilTKeanePAUpdikeJFRelationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edemaOphthalmology2010117122379238620561684
   PubMed Web of Science ®Google Scholar
• UjiAMurakamiTNishijimaKAssociation between hyper-reflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edemaAm J Ophthalmol2012153471071722137207
   PubMed Web of Science ®Google Scholar
• SakamotoANishijimaKKitaMOhHTsujikawaAYoshimuraNAssociation between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomyGraefes Arch Clin Exp Ophthalmol2009247101325133019430805
   PubMed Web of Science ®Google Scholar
• BonninSTadayoniRErginayAMassinPDupasBCorrelation between ganglion cell layer thinning and poor visual function after resolution of diabetic macular edemaInvest Ophthalmol Vis Sci201556297898225574055
   PubMed Web of Science ®Google Scholar
• CarpinetoPCiancagliniMDi AntonioLGavalasCMastropasquaLFundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edemaRetina2007271212917218911
   PubMed Web of Science ®Google Scholar
• VujosevicSPilottoEBottegaEBenettiECavarzeranFMidenaERetinal fixation impairment in diabetic macular edemaRetina200828101443145018997608
   PubMed Web of Science ®Google Scholar
• Dubois-RousselCDupasBErginayAMassinPTadayoniRIncreased fixation stability after intravitreal treatment for chronic diabetic macular edema: a marker of favorable visual outcomePoster 1777 – A0210 presented at: 2015 Annual meeting of the Association for Research in Vision and Ophtalmology (ARVO)May 3–7, 2015Denver, Colorado
   Google Scholar
• Schmit-EilenbergerVKA novel intravitreal fluocinolone acetonide implant (Iluvien®) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case seriesClin Ophthalmol2015980181125999689
   PubMed Web of Science ®Google Scholar
• DowneyLChakravarthyUExploratory analyses of long-term visual outcomes based on baseline vision in patients with chronic and nonchronic diabetic macular oedema (DMO) treated with fluocinolone acetonide (FAc)Poster 221 presented at: Annual Congress 2015 of the The Royal College of OphthalmologistsMay 19–21, 2015Liverpool, UK
   Google Scholar